Seattle, WA · Founded 2023 · Privately Held (backing)
Developer of a biotechnology platform designed to engineer de novo biologics for the treatment of complex diseases. Accipiter Biosciences is based in Seattle, WA and was founded in 2023. It was valued at $22 million at its seed round in Nov 2025, the last priced event on record. It has raised $13.6 million across 2 recorded rounds; the latest was a $13.6 million early-stage round in May 2024.
PMV mark · valuation
$22.0M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$13.6M
Last round
Early Stage VC
May 2024
Team — not yet on record
No current team members for Accipiter Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Accipiter Biosciences with a free account
·Watch Accipiter Biosciences: the Monday email on marks, rounds and moves
